| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.05B | +3.3% |
| Cost of Revenue | $17.41B | -0.2% |
| Gross Profit | $10.95B | — |
| R&D Expense | $6.51B | -8.1% |
| SG&A Expense | $15.26B | +23.6% |
| Operating Income | $18.12B | +1.1% |
| Interest Expense | $2.23B | -8.0% |
| Pre-tax Income | $13.48B | +3.8% |
| Income Tax | $1.63B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.20B | -5.6% |
| Short-term Investments | $28.0M | -66.7% |
| Accounts Receivable | $11.25B | +12.8% |
| Inventory | $3.58B | +14.4% |
| Current Assets | $28.46B | +1.9% |
| Total Assets | $138.81B | -5.3% |
| Current Liabilities | $29.54B | -16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.94B | +9.5% |
| Capital Expenditures | $695.0M | -11.7% |
| Investing Cash Flow | -$623.0M | +73.4% |
| Financing Cash Flow | -$24.80B | -30.3% |
| Free Cash Flow | $24.25B | +10.3% |
| +13.3% |
| Net Income | $11.84B | +2.5% |
| EPS (Basic) | $6.65 | +2.6% |
| EPS (Diluted) | $6.63 | +2.8% |
| Long-term Debt |
| $63.13B |
| -16.9% |
| Stockholders' Equity | $17.25B | +12.0% |